Tisokinase

Drug Profile

Tisokinase

Alternative Names: AK 124; Hapase; Plasvata

Latest Information Update: 22 Apr 2016

Price : $50

At a glance

  • Originator Asahi Kasei
  • Developer Asahi Kasei; Kowa
  • Class Plasminogen activator enzymes; Thrombolytics
  • Mechanism of Action Plasminogen activator stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Intracranial thrombosis; Myocardial infarction

Most Recent Events

  • 15 Jan 2001 Asahi Chemical is now called Asahi Kasei
  • 12 Jan 1996 Launched for Cerebral thrombosis in Japan (IV)
  • 05 Jan 1996 Launched for Myocardial infarction in Japan (Intra-arterial)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top